跳至主要内容
临床试验/NCT07596732
NCT07596732尚未招募不适用

Statewide Unified Network for Remote Intervention of Strength and Exercise

AdventHealth Translational Research Institute0 个研究点目标入组 120 人开始时间: 2026年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
120
主要终点
Chemotherapy Relative Dose Intensity

研究概览

简要总结

This study will evaluate whether a remotely delivered exercise program can improve chemotherapy tolerability in patients with gastrointestinal or lung cancer receiving chemotherapy.

In this decentralized, digital randomized clinical trial, up to 120 adults with gastrointestinal or lung cancer will be randomized to either a home-based aerobic and resistance exercise program or home-based progressive stretching program. All study activities will be conducted remotely using digital technologies and home-based assessments. Participants in both groups will receive Bluetooth-enabled wearable devices for monitoring physical activity, body weight, blood pressure, and other health measures.

The primary objective is to determine whether exercise improves chemotherapy relative dose intensity compared with stretching. The intervention will continue throughout chemotherapy treatment or for up to 32 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Gastrointestinal cancer (esophageal, gastric, pancreatic, colon, and rectal) treated with chemotherapy (and other treatments, as clinically indicated) before surgery OR Lung cancer (non-small cell and small-cell) treated with chemotherapy (and other treatments, as clinically indicated) for advanced- or extensive-stage disease.
  • Completion of the modified version of the Physical Activity Readiness Questionnaire.

排除标准

  • Actively treated for another non-gastrointestinal or non-lung malignancy (surveillance with observation is allowed).
  • Engage in more than 150 minutes per week of aerobic physical activity and two or more sessions of muscle strengthening activity per week over the last three months (self-report).
  • Unable to walk for 6 minutes or two city blocks independently (self-report).
  • Enrollment in another study that intervenes upon physical activity, diet, or body composition as a primary objective (self-report).
  • Unable to read and speak English.
  • No access to a reliable internet connection.
  • Currently an AdventHealth employee.

研究组 & 干预措施

Exercise

Experimental

The exercise group will engage in aerobic and muscle-strengthening activities.

干预措施: Exercise (Behavioral)

Stretching

Active Comparator

The stretching group will engage in whole-body static stretching activities.

干预措施: Stretching (Behavioral)

结局指标

主要结局

Chemotherapy Relative Dose Intensity

时间窗: Up to 32 weeks

The ratio of the delivered dose intensity to the standard or planned dose intensity.

次要结局

未报告次要终点

研究者

发起方
AdventHealth Translational Research Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Justin Brown

Director, Exercise & Cancer Biology Research Program

AdventHealth Translational Research Institute

相似试验